Growth Opportunity Assessment of Antinuclear Antibody Test Market 2024
North America is expected to lead the global antinuclear antibody test market followed by Europe, Asia, and the Rest of the World. The major reason for the North American market growth is primarily due to the high incidence of autoimmune diseases, healthcare spending, growing population, and rising number of individuals having medical insurance in the U.S.
View full press release